Form 8-K - Current report:
SEC Accession No. 0001193125-21-251050
Filing Date
2021-08-19
Accepted
2021-08-19 08:10:56
Documents
13
Period of Report
2021-08-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d366493d8k.htm   iXBRL 8-K 22035
2 EX-99.1 d366493dex991.htm EX-99.1 28284
  Complete submission text file 0001193125-21-251050.txt   171924

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ck0001175680-20210819.xsd EX-101.SCH 2939
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001175680-20210819_lab.xml EX-101.LAB 16083
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001175680-20210819_pre.xml EX-101.PRE 10144
6 EXTRACTED XBRL INSTANCE DOCUMENT d366493d8k_htm.xml XML 3009
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 211188467
SIC: 2834 Pharmaceutical Preparations